Exposure to human chorionic gonadotropin during in vitro maturation does not improve the maturation rate and developmental potential of immature oocytes from patients with polycystic ovary syndrome - Ge, Hong-Shan; Huang, Xue-Feng; Zhang, Wei; Zhao, Jun-Zhao; Lin, Jin-Jun; Zhou, Wei (Fertility and sterility, 2008)
Keywords: Adult; Biological and medical sciences; Cell Culture Techniques; Chorionic Gonadotropin - pharmacology; Chorionic Gonadotropin - therapeutic use; Culture Media; Embryo Culture Techniques; Embryo Implantation - drug effects; Embryo Transfer; Female; Female genital diseases; Fertility Agents, Female - pharmacology; Fertility Agents, Female - therapeutic use; Fertilization - drug effects; Fertilization in Vitro; Gynecology. Andrology. Obstetrics; hCG; Humans; In vitro maturation; Infertility, Female - etiology; Infertility, Female - physiopathology; Infertility, Female - therapy; Internal Medicine; maturation culture medium; Medical sciences; Non tumoral diseases; Obstetrics and Gynecology; Oocyte Retrieval; Oocytes - drug effects; Oocytes - growth & development; polycystic ovary syndrome; Polycystic Ovary Syndrome - complications; Polycystic Ovary Syndrome - physiopathology; Polycystic Ovary Syndrome - therapy; Pregnancy; Pregnancy Outcome; Prospective Studies; Time Factors; Treatment Outcome; maturation culture medium; hCG; In vitro maturation; polycystic ovary syndrome; Human; Culture medium; Gynecology; Rate; Female sterility; Exposure; Polycystic ovary; In vitro; Obstetrics; Female genital diseases; Ripening; Protein hormone; Ovarian diseases; Human chorionic gonadotrophin; Cyst; Development; Chorionic gonadotrophin; Benign neoplasm; Immaturity; Oocyte